2016-04-13
Today, CellaVision announced that the company's Annual Report for 2015 is available as PDF at www.cellavision.com, and can be read via the link below.
To request a printed version, please visit the investor pages at CellaVision's website.
For more information, please contact:
Zlatko Rihter, CEO, CellaVision AB
Zlatko Rihter, CEO, CellaVision AB
Phone: +46 733 62 11 06 | E-mail: zlatko.rihter@cellavision.com
About CellaVision
CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The analyses often constitute important reference data for fast and correct diagnosis of illnesses such as viral and bacterial infections and cancers. CellaVision's products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in image analysis, artificial intelligence and automated microscopy. In 2015 sales were SEK 239 million. Sales continue to increase, with a growth target of at least 15 % per year over an economic cycle. CellaVision's head office is in Lund, Sweden and the company has subsidiaries in the USA, Canada and Japan. The share is listed on the Nasdaq Stockholm, Small Cap list. Read more at www.cellavision.com
